Overview

Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York

Read Press Release

Latest Financial Results

Q2 2017

Quarterly Results

Jun 30, 2017

Stock Information

OTCQB:

COCP

Price

Loading...

Change

Loading...

Mkt Cap

Loading...

Volume

Loading...
52 week Low/High Loading...
Day Low/High Loading...

Company Overview

Cocrystal Pharma, Inc. is a pharmaceutical company with a mission to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal Pharma employs unique nucleoside chemistry and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies and our market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer.